🇨🇦 Bimatoprost .03% sterile ophthalmic solution in Canada

Bimatoprost .03% sterile ophthalmic solution (Bimatoprost .03% sterile ophthalmic solution) regulatory status in Canada.

Marketing authorisation

Bimatoprost .03% sterile ophthalmic solution in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bimatoprost .03% sterile ophthalmic solution approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Bimatoprost .03% sterile ophthalmic solution in Canada?

Federal University of São Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.